With 47,704 COVID-19 cases in single day, India’s virus tally mounted to 14,83,156 on Wednesday. The recoveries surged to 9,52,743, according to the Union Health Ministry data.
This is the sixth consecutive day that COVID-19 cases have increased by more than 45,000.
The country’s death toll due to the virus rose to 33,425 with 654 deaths being reported in a 24-hour span.
There are 4,96,988 active cases of coronavirus infection in the country presently. According to the data, the recovery among COVID-19 patients is 64.24 percent, while the fatality rate is 2.25 percent.
Karnataka and Andhra Pradesh have surpassed one lakh coronavirus cases. Both the states recorded a daily spike of over 5,000 each.
Karnataka, which had been praised weeks ago for containing the virus, on July 27 ,reported its highest one-day tally of 5,324 cases, taking the total of those infected to 1,01,465. The state’s capital, Bengaluru, reported 1,470 new cases in a day and its total stands at 46,943.
Andhra Pradesh, which had reported 7,627 covid-19 cases on Sunday, took its total from 96,298 to 1,02,349 in a day.
According to a study conducted in Telengana,it appears that women in the age group of 21-30 are most susceptible to catching the virus, with 7.9 percent cases in women being reported from that bracket.
Meanwhile five sites across the country are ready for the third and final phase of human trials of the Oxford- AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology(DBT) Renu Swarup said.
This is an essential step because it is necessary to have data within the country before the vaccine is administered to Indians.
The Pune-based Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready.
